Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 781-787

  Chow, Lillian Shuk Nga ^a   Lo, Kwok Wai ^a   Kwong, Joseph ^a   Wong, Albert Yue Hang ^a   Huang, Dolly P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Methylation; Nasopharyngeal carcinoma; NORE1; RASSF4 AD037

Indexed keywords

AZACITIDINE; DNA; MESSENGER RNA; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RASSF4 PROTEIN, HUMAN; RASSF5 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL CULTURE; DNA METHYLATION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NASOPHARYNX TUMOR; PROMOTER REGION; SEQUENCE HOMOLOGY; XENOGRAFT;

AMINO ACID SEQUENCE; APOPTOSIS; AZACITIDINE; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; GENE SILENCING; HUMANS; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 16644386049     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.781     Document Type: Article

References (25)

1. Lee AWM, Foo W, Mang O, Sze WM, Chappell R, Lau WH and Ko WH: Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality. Int J Cancer 103: 680-685, 2003. (Pubitemid 36091475)
2. Lo KW and Huang DP: Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12: 451-462, 2002.
3. Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196, 1998. (Pubitemid 27435555)
4. Kwong J, Lo KW, To KF, Teo PML, Johnson PJ and Huang DP: Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8: 131-137, 2002. (Pubitemid 34101468)
5. Lo KW, Cheung ST, Leung SF, van Hasselt A, Tsang YS, Mak KF, Chung YF, Woo JKS, Lee JCK and Huang DP: Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 56: 2721-2725, 1996. (Pubitemid 26175726)
6. Lo KW, Kwong J, Hui ABY, Chan SYY, To KF, Chan ASC, Chow LSN, Teo PML, Johnson PJ and Huang DP: High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61: 3877-3881, 2001. (Pubitemid 32720944)
7. Lerman MI and Minna JD: The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 60: 6116-6133, 2000.
8. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP: Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat Genet 25: 315-319, 2000. (Pubitemid 30437320)
9. Byun DS, Lee MG, Chae KS, Ryu BG and Chi SG: Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 61: 7034-7038, 2001.
10. Chow LSN, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R and Huang DP: RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer (In press).
11. Dammann R, Yang G and Pfeifer GP: Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 61: 3105-3109, 2001. (Pubitemid 32691961)
12. Burbee DG, Forgacs E, Zöchbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M and Minna JD: Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699, 2001. (Pubitemid 32492810)
13. Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP and Dammann R: Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res 62: 3698-3701, 2001.
14. Kuzmin I, Gillespie JW, Protopopov A, Geil L, Dreijerink K, Yang Y, Vocke CD, Duh FM, Zabarovsky E, Minna JD, Rhim JS, Emmert-Buck MR, Linehan WM and Lerman MI: The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res 62: 3498-3502, 2002. (Pubitemid 34651398)
15. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G and Zabarovsky ER: The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 98: 7504-7509, 2001. (Pubitemid 32567978)
16. Tommasi S, Dammann R, Jin SG, Zhang XF, Avruch J and Pfeifer GP: RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene 21: 2713-2720, 2003. (Pubitemid 34478329)
17. Hesson L, Dallol A, Minna JD, Maher ER and Latif F: NORE1A, a homologue of RASSF1A tumor suppressor gene is inactivated in human cancers. Oncogene 22: 947-954, 2003. (Pubitemid 36255830)
18. Vos MD, Martinez A, Ellis CA, Vallecorsa T and Clark GJ: The pro-apoptotic Ras effector Norel may serve as a Ras regulated tumor suppressor in the lung. J Biol Chem 278: 21938-21943, 2003.
19. Morris MR, Hesson LB, Wagner KJ, Morgan NV, Astuti D, Lees RD, Cooper WN, Lee J, Gentle D, MacDonald F, Kishida T, Grundy R, Yao M, Latif F and Maher ER: Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma. Oncogene 22: 6794-6801, 2003. (Pubitemid 37372219)
20. Vavvas D, Li X, Avruch J and Zhang XF: Identification of Nore1 as a potential Ras effector. J Biol Chem 273: 5439-5442, 1998. (Pubitemid 28124004)
21. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP and Avruch J: The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncogene 21: 1381-1390, 2002. (Pubitemid 34214503)
22. Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF, Seed B and Avruch J: Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 12: 253-265, 2002. (Pubitemid 34161469)
23. Porter MJ, Field JK, Leung SF, Lo D, Lee JC, Spandidos DA and van Hasselt CA: The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 114: 105-109, 1994. (Pubitemid 24009244)
24. Thompson JD, Higgins DG and Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680, 1994. (Pubitemid 24354800)
25. Goodstadt L and Ponting CP: CHROMA: consensus-based colouring of multiple alignments for publication. Bioinformatics 17: 845-846, 2001. (Pubitemid 32970485)